ENANTA PHARMACEUTICALS INC Quarterly Operating Lease, Right-of-Use Asset in USD from Q3 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Enanta Pharmaceuticals Inc quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q3 2019 to Q2 2024.
  • Enanta Pharmaceuticals Inc Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $41.2M, a 71.9% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $41.2M +$17.2M +71.9% Jun 30, 2024 10-Q 2024-08-07
Q1 2024 $42.9M +$18.3M +74.7% Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $21.3M -$2.2M -9.33% Dec 31, 2023 10-Q 2024-02-08
Q3 2023 $22.8M -$781K -3.31% Sep 30, 2023 10-Q 2024-08-07
Q2 2023 $24M +$475K +2.02% Jun 30, 2023 10-Q 2023-08-08
Q1 2023 $24.6M +$7.34M +42.6% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $23.5M +$4.71M +25% Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $23.6M +$18.9M +400% Sep 30, 2022 10-K 2023-11-22
Q2 2022 $23.5M +$17.6M +297% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 $17.2M +$10.2M +147% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 $18.8M +$11.1M +142% Dec 31, 2021 10-Q 2022-02-10
Q3 2021 $4.71M -$2.31M -32.9% Sep 30, 2021 10-K 2022-11-23
Q2 2021 $5.92M -$1.73M -22.6% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 $6.97M -$865K -11% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 $7.78M +$13K +0.17% Dec 31, 2020 10-Q 2021-02-09
Q3 2020 $7.02M -$1.6M -18.6% Sep 30, 2020 10-K 2021-11-24
Q2 2020 $7.65M Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $7.84M Mar 31, 2020 10-Q 2020-05-11
Q4 2019 $7.76M Dec 31, 2019 10-Q 2020-02-10
Q3 2019 $8.62M Oct 1, 2019 10-K 2021-11-24
* An asterisk sign (*) next to the value indicates that the value is likely invalid.